Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BIOLASE, Inc. stock logo
BIOL
BIOLASE
$0.01
-1.1%
$0.01
$0.02
$1.94
$304K0.672.58 million shs77,354 shs
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
$0.00
$0.00
$0.10
$70K0.7713.46 million shs25 shs
NBHGF
Nobel Biocare
$18.25
$0.00
$16.35
$19.50
N/A-0.01N/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
$1.15
$1.23
$1.00
$17.00
$493K1.51,012 shs1 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BIOLASE, Inc. stock logo
BIOL
BIOLASE
0.00%-6.60%-14.81%-23.97%-89.86%
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
0.00%0.00%0.00%0.00%0.00%
NBHGF
Nobel Biocare
0.00%0.00%0.00%0.00%0.00%
Sonendo, Inc. stock logo
SONX
Sonendo
0.00%0.00%0.00%-7.26%+1,372.47%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BIOLASE, Inc. stock logo
BIOL
BIOLASE
0.9804 of 5 stars
3.50.00.00.00.60.00.0
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
N/AN/AN/AN/AN/AN/AN/AN/A
NBHGF
Nobel Biocare
N/AN/AN/AN/AN/AN/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BIOLASE, Inc. stock logo
BIOL
BIOLASE
3.00
Buy$1.2013,086.81% Upside
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
0.00
N/AN/AN/A
NBHGF
Nobel Biocare
0.00
N/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BIOLASE, Inc. stock logo
BIOL
BIOLASE
$48.83M0.01N/AN/A($0.07) per share-0.13
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
$21.76M0.00N/AN/AN/ANaN
NBHGF
Nobel Biocare
N/AN/AN/AN/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
$44.40M0.01N/AN/A$89.42 per share0.01
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BIOLASE, Inc. stock logo
BIOL
BIOLASE
-$20.63M-$14.94N/AN/A-41.65%-1,782.73%-55.31%8/6/2025 (Estimated)
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
-$31.14MN/A0.00N/AN/AN/AN/AN/AN/A
NBHGF
Nobel Biocare
N/AN/A0.00N/AN/AN/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
-$60.92M-$59.12N/AN/A-92.74%-184.01%-68.60%8/8/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BIOLASE, Inc. stock logo
BIOL
BIOLASE
N/AN/AN/AN/AN/A
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
N/AN/AN/AN/AN/A
NBHGF
Nobel Biocare
N/AN/AN/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BIOLASE, Inc. stock logo
BIOL
BIOLASE
N/A
0.71
0.36
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
N/AN/AN/A
NBHGF
Nobel Biocare
N/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
0.55
1.82
1.22

Institutional Ownership

CompanyInstitutional Ownership
BIOLASE, Inc. stock logo
BIOL
BIOLASE
8.79%
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
N/A
NBHGF
Nobel Biocare
N/A
Sonendo, Inc. stock logo
SONX
Sonendo
28.68%

Insider Ownership

CompanyInsider Ownership
BIOLASE, Inc. stock logo
BIOL
BIOLASE
0.27%
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
19.80%
NBHGF
Nobel Biocare
N/A
Sonendo, Inc. stock logo
SONX
Sonendo
7.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
BIOLASE, Inc. stock logo
BIOL
BIOLASE
16033.41 million33.32 millionNot Optionable
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
100701.92 million562.85 millionNot Optionable
NBHGF
Nobel Biocare
N/AN/AN/ANot Optionable
Sonendo, Inc. stock logo
SONX
Sonendo
250429,000393,000Not Optionable

Recent News About These Companies

Sonendo Inc.
Sonendo, Inc. (SONX) Q2 2024 Earnings Call Transcript
Here's what Wall Street expects from Sonendo's earnings report
Sonendo, Inc. (SONX)

New MarketBeat Followers Over Time

Media Sentiment Over Time

BIOLASE stock logo

BIOLASE NASDAQ:BIOL

$0.0091 0.00 (-1.09%)
As of 07/16/2025

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

Item 9 Labs stock logo

Item 9 Labs OTC:INLB

Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.

Sonendo stock logo

Sonendo NYSE:SONX

$1.15 0.00 (0.00%)
As of 07/16/2025

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.